Sanz MÁ - Search Results

1

Pharmacogenomics and the treatment of acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: sanz ma. Pharmacogenomics. 2016 Jul;17(11):1245-1272. doi: 10.2217/pgs-2016-0055. Epub 2016 Jul 6. Pharmacogenomics. 2016. PMID: 27381050 Review.

2

Carboplatin alone or in combination in high-risk acute nonlymphoblastic leukemia.

Sanz MA, Sanz GF, Martínez JA, Senent L, López F, Palau J, Martín G, Jarque I. Sanz MA, et al. Among authors: sanz gf. Ann Oncol. 1992 Aug;3 Suppl 3:39-42. doi: 10.1093/annonc/3.suppl_3.s39. Ann Oncol. 1992. PMID: 1390315 Review.

3

[Hyperleukocytic acute leukemia. Clinico-biological characterization, response to treatment and prognostic factors].

Senent L, Sanz GF, Jarque I, De la Rubia J, Sanz MA. Senent L, et al. Among authors: sanz ma, sanz gf. Sangre (Barc). 1992 Feb;37(1):25-30. Sangre (Barc). 1992. PMID: 1585234 Spanish.

4

Acute promyelocytic leukemia. Therapy results and prognostic factors.

Sanz MA, Jarque I, Martín G, Lorenzo I, Martínez J, Rafecas J, Pastor E, Sayas MJ, Sanz G, Gomis F. Sanz MA, et al. Among authors: sanz g. Cancer. 1988 Jan 1;61(1):7-13. doi: 10.1002/1097-0142(19880101)61:1<7::aid-cncr2820610103>3.0.co;2-6. Cancer. 1988. PMID: 3422032

5

Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution.

Sanz MA, de la Rubia J, Sanz GF, Martín G, Martínez J, Jarque I, Sempere A, Gomis F, Senent L, Soler MA, et al. Sanz MA, et al. Among authors: sanz gf. J Clin Oncol. 1993 Sep;11(9):1661-7. doi: 10.1200/JCO.1993.11.9.1661. J Clin Oncol. 1993. PMID: 8102640

6

Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases.

Sempere A, Jarque I, Guinot M, Palau J, García R, Sanz GF, Gomis F, Pérez-Sirvent ML, Senent L, Sanz MA. Sempere A, et al. Among authors: sanz ma, sanz gf. Leuk Lymphoma. 1993 Dec;12(1-2):103-8. doi: 10.3109/10428199309059577. Leuk Lymphoma. 1993. PMID: 8161925

7

Filgrastim for the treatment of leukemia relapse after bone marrow transplantation.

Carral A, Sanz GF, Sanz MA. Carral A, et al. Among authors: sanz ma, sanz gf. Bone Marrow Transplant. 1996 Oct;18(4):817-9. Bone Marrow Transplant. 1996. PMID: 8899204

8

Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.

de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA. de la Rubia J, et al. Among authors: sanz ma, sanz gf. Bone Marrow Transplant. 1996 Dec;18(6):1167-73. Bone Marrow Transplant. 1996. PMID: 8971390 Clinical Trial.

9

P-glycoprotein expression and prognostic value in acute myeloid leukemia.

Senent L, Jarque I, Martín G, Sempere A, González-García Y, Gomis F, Pérez-Sirvent M, De La Rubia J, Sanz MA. Senent L, et al. Among authors: sanz ma. Haematologica. 1998 Sep;83(9):783-7. Haematologica. 1998. PMID: 9825574

10

Carboplatin plus cytarabine in the treatment of high-risk acute myeloblastic leukemia.

Larrea L, Martínez JA, Sanz GF, Martín G, de la Rubia J, Jiménez C, Jarque I, Cid A, López A, Sanz MA. Larrea L, et al. Among authors: sanz ma, sanz gf. Leukemia. 1999 Feb;13(2):161-5. doi: 10.1038/sj.leu.2401278. Leukemia. 1999. PMID: 10025888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page